CMS payment rate increases 2.2% for dialysis facilities
CMS issued its final rule for the End-Stage Renal Disease Prospective Payment System base rate for dialysis facilities to $281.71 beginning Jan. 1, 2026, according to an agency press release. The final rate increased $7.89 from the calendar year 2025 base rate of $273.82. The rate will apply to all ESRD facilities, with hospital-based facilities…
Kidney News in Brief: New Kidney Care Partners Chair Shares 2026 Priorities
LaVarne A. Burton, president and chief executive officer of the American Kidney Fund, has begun her 2-year term as chair of Kidney Care Partners (KCP), a coalition of patient advocates, physician organizations, health professional groups, dialysis providers, researchers, and manufacturers. Click here to read the full article.
Politico Influence: Jobs Report
— Kidney Care Partners has named American Kidney Fund president and CEO LaVarne Burton as its new chair. Click here to read the full article.
LaVarne A. Burton – New Chair of Nation’s Largest Kidney Care Coalition – Outlines 2026 Kidney Community Priorities
Burton to Focus on Supporting Patient Choice, Expanding Access to Innovative Treatments to Improve Patient-Centric Kidney Care WASHINGTON – Kidney Care Partners (KCP) – the nation’s leading kidney care multi-stakeholder coalition representing patient advocates, physician organizations, health professional groups, dialysis providers, researchers and manufacturers—is pleased to announce LaVarne A. Burton as its new chair. As…
Nation’s Largest Kidney Care Coalition Elects New Leadership to Represent Policy Priorities Impacting Patients, Kidney Care
WASHINGTON – Kidney Care Partners (KCP)—the nation’s largest non-profit, non-partisan kidney care coalition representing patients, dialysis professionals, physicians, nurses, researchers, therapeutic innovators, transplant coordinators, and manufacturers—today announced that Keith A. Bellovich, DO has been selected by his peers to succeed American Kidney Fund CEO LaVarne A. Burton as Chair-Elect of the organization. A practicing nephrologist,…
Kidney Care Partners Statement on 2026 ESRD PPS Final Rule
Nation’s Largest Kidney Care Coalition Urges Congress to Pass the Kidney Care Access Protection Act (S. 2730/H.R. 6214) WASHINGTON – Kidney Care Partners (KCP)—the nation’s leading kidney care multi-stakeholder coalition representing patient advocates, physician organizations, health professional groups, dialysis providers, researchers, and manufacturers—today released the following statement in reaction to the Centers for Medicare &…
Miller Introduces Kidney Care Access Protection Act
Today, Congresswoman Carol Miller (R-WV) along with Congresswoman Terri Sewell (D-AL) introduced the Kidney Care Access Protection Act (KCAPA). This bipartisan bill will strengthen Medicare’s kidney care benefits by ensuring sustainable reimbursement for dialysis providers, expanding access to patient education resources, and supporting a long-term payment pathway for new therapies and emerging technologies. Click here to read…
Kidney Care Partners Commends House Introduction of Kidney Care Access Protection Act
WASHINGTON – Kidney Care Partners (KCP)—the nation’s largest non-profit, non-partisan kidney care coalition representing patients, dialysis professionals, physicians, nurses, researchers, therapeutic innovators, transplant coordinators, and manufacturers—today expressed appreciation to Representatives Carol Miller (R-WV) and Terri Sewell (D-AL) for introducing the bipartisan Kidney Care Access Protection Act (KCAPA) in the House of Representatives. A bipartisan Senate…
Kidney Care Partners Commends House Ways and Means Committee’s Focus on Chronic Kidney Disease Coordination, Prevention
Nation’s Largest Kidney Care Coalition Urges Lawmakers to Stabilize, Modernize Medicare’s Kidney Care Benefit to Ensure Access to Quality Care, Innovations WASHINGTON – Kidney Care Partners (KCP)—the nation’s leading kidney care multi-stakeholder coalition representing patient advocates, physician organizations, health professional groups, dialysis providers, researchers, and manufacturers—commended the House Ways and Means Subcommittee on Health for…
We’re overdue for a kidney care refresh
Medicare policies for end-stage renal disease have had a chilling effect on innovation in patient care. It’s 2025, and it’s time to confront a hard truth: Medicare’s kidney disease care benefit isn’t perfect, and in many ways, it’s failing the individuals it was intended to protect – those living with kidney failure, or end-stage renal…